The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: Results from the MRC RT01 trial (ISRCTN47772397)

This publication has 31 references indexed in Scilit:

• Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate
  JAMA, 2005
• Technological advances in radiotherapy for the treatment of localised prostate cancer
  Published by Elsevier ,2005
• Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy
  International Journal of Radiation Oncology*Biology*Physics, 2005
• Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects
  British Journal of Cancer, 2005
• Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer
  Radiotherapy and Oncology, 2004
• Class solutions for conformal external beam prostate radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 2003
• Preliminary Results of a Randomized Radiotherapy Dose-Escalation Study Comparing 70 Gy With 78 Gy for Prostate Cancer
  Journal of Clinical Oncology, 2000
• An evaluation of three-field coplanar plans for conformal radiotherapy of prostate cancer
  Radiotherapy and Oncology, 2000
• Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial
  The Lancet, 1999
• Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 1994